Newsfeed : China Revokes Patent for Viread

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Newsfeed » August 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

August 8, 2013

China Revokes Patent for Viread

The patent on Viread has been revoked by China, BioWorld reports. The Gilead Sciences drug, which is its third best seller worldwide, has been at the heart of China’s push to get pharmaceutical companies to become more flexible with the pricing of lifesaving drugs around the world. Experts say taking away the patent for the HIV/AIDS and hepatitis B virus (HBV) drug will open the door for tenofovir, its active ingredient, to be produced generically and allow China to export the cheaper version of the drug to other countries. The high price of Viread ($240 for a 30-pack of 300 milligram pills) has put treatment for both diseases beyond the reach of many patients worldwide, who often have to pay much of their medical expenses out-of-pocket. China’s intellectual property office revoked the patent after a challenge by Aurisco, the largest pharmaceutical manufacturer in China, claimed the drug lacked novelty and was not entitled to protection.

To read the article, click here.

Search: China, Viread, patent, Gilead Sciences, tenofovir, HIV, hepatitis B, HBV, intellectual property, Aurisco


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    chipper52
    Palm Springs
    California


    romanticseattle
    Tacoma
    Washington


    Fred9774
    Brooklyn
    New York


    jap022964
    el dorado
    Arkansas
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Are you a regular coffee drinker?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.